Literature DB >> 22328545

Appraisal of the Glasgow assessment and management of alcohol guideline: a comprehensive alcohol management protocol for use in general hospitals.

A McPherson1, G Benson, E H Forrest.   

Abstract

BACKGROUND: Guidelines exist for the management of alcohol withdrawal syndrome (AWS) but few have been assessed as to their suitability for general hospitals. The Glasgow Assessment and Management guideline for alcohol has been specifically developed for use in this context. AIM: To determine if this alcohol assessment guideline aids the management of AWS in general hospitals.
DESIGN: The four components of the Glasgow Assessment and Management of Alcohol guideline were evaluated. This included the use of the Fast Alcohol Screening Test (FAST) to identify at risk patients, a risk stratification strategy to indicate fixed dose or symptom-triggered benzodiazepine treatment, the Glasgow Modified Alcohol Withdrawal Scale (GMAWS) for symptom-triggered treatment and a clear recommendation for vitamin prophylaxis of Wernicke's encephalopathy.
METHODS: FAST scores were assessed along with the CAGE (cut down, annoyed, guilty and eye-opener) screening tool to ascertain if a single screening tool could identify hazardous and dependent drinking. The GMAWS and Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar) were compared between two medical units. A staff survey of the two AWS tools was also carried out.
RESULTS: FAST was able to identify both probable hazardous and dependent drinking. The GMAWS was reliable and gauged both physical and cognitive aspects of AWS. Staff generally preferred the GMAWS-based treatment as opposed to CIWA-Ar management and welcomed the Guideline as a whole.
CONCLUSION: The Glasgow Guideline aids the management of patients with AWS in an acute hospital setting. It allows early identification of at risk patients and directs effective therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22328545     DOI: 10.1093/qjmed/hcs020

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  4 in total

1.  Clinical Institute Withdrawal Assessment for Alcohol-Revised might be an unreliable tool in the management of alcohol withdrawal.

Authors:  Erin Knight; Leslie Lappalainen
Journal:  Can Fam Physician       Date:  2017-09       Impact factor: 3.275

2.  Randomised trial of intravenous thiamine and/or magnesium sulphate administration on erythrocyte transketolase activity, lactate concentrations and alcohol withdrawal scores.

Authors:  Donogh Maguire; Alana Burns; Dinesh Talwar; Anthony Catchpole; Fiona Stefanowicz; David P Ross; Peter Galloway; Alastair Ireland; Gordon Robson; Michael Adamson; Lesley Orr; Joanna-Lee Kerr; Xenofon Roussis; Eoghan Colgan; Ewan Forrest; David Young; Donald C McMillan
Journal:  Sci Rep       Date:  2022-04-28       Impact factor: 4.996

3.  Diagnostic Performance of AST Scale in Mexican Male Population for Alcohol Withdrawal Syndrome.

Authors:  Juan Antonio Suárez-Cuenca; Christian Gabriel Toledo-Lozano; Maryjose Daniela Espinosa-Arroyo; Nallely Alejandra Vázquez-Aguirre; Gandhy Thomas Fonseca-González; Karen Garro-Almendaro; Alberto Melchor-López; Victor Hugo García-López; Abril Ortiz-Matamoros; Tania Ortega-Rosas; Sofia Lizeth Alcaraz-Estrada; Paul Mondragón-Terán; Silvia García
Journal:  Int J Environ Res Public Health       Date:  2022-07-28       Impact factor: 4.614

4.  A prospective evaluation of thiamine and magnesium status in relation to clinicopathological characteristics and 1-year mortality in patients with alcohol withdrawal syndrome.

Authors:  Donogh Maguire; Dinesh Talwar; Alana Burns; Anthony Catchpole; Fiona Stefanowicz; Gordon Robson; David P Ross; David Young; Alastair Ireland; Ewan Forrest; Peter Galloway; Michael Adamson; Eoghan Colgan; Hannah Bell; Lesley Orr; Joanna-Lee Kerr; Xen Roussis; Donald C McMillan
Journal:  J Transl Med       Date:  2019-11-21       Impact factor: 5.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.